World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
54167
World Ranking
5476
National Ranking
2950

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

John Varga is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on multiple areas within medicine, with a strong emphasis on systemic sclerosis and related diseases.

The main fields of study for John Varga encompass medicine, including several specialized subfields such as pathology and forensic medicine, pulmonary and respiratory medicine, epidemiology, dermatology, and immunology. Their work covers a range of key topics, including systemic sclerosis and related diseases, interstitial lung diseases and idiopathic pulmonary fibrosis, inflammatory myopathies and dermatomyositis, dermatologic treatments and research, mast cells and histamine, eosinophilic disorders and syndromes, and body image and dysmorphia studies.

The scientist has collaborated frequently with several coauthors, including:

  • Dinesh Khanna
  • Swati Bhattacharyya
  • Pei-Suen Tsou
  • Swarna Bale
  • Monique Hinchcliff

John Varga has published extensively in a number of scientific journals. Their frequent publication venues are:

  • Journal of Investigative Dermatology
  • JCI Insight
  • Arthritis & Rheumatology
  • Current Opinion in Rheumatology
  • bioRxiv (Cold Spring Harbor Laboratory)

Recent papers authored or co-authored by John Varga include:

  • Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease, 2020, Arteriosclerosis Thrombosis and Vascular Biology
  • 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases, 2024, Arthritis & Rheumatology
  • Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential, 2021, Nature Reviews Rheumatology
  • 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases, 2024, Arthritis & Rheumatology
  • Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications, 2021, Current Opinion in Rheumatology

John Varga has been recognized as a member of the Association of American Physicians.

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: Developed in Collaboration With the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Systemic sclerosis: a prototypic multisystem fibrotic disorder.

    John Varga;David Abraham

  • ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

    Vallerie V. McLaughlin;Stephen L. Archer;David B. Badesch;Robyn J. Barst

  • Recent developments in myofibroblast biology: paradigms for connective tissue remodeling.

    Boris Hinz;Sem H. Phan;Victor J. Thannickal;Marco Prunotto

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts.

    J Varga;J Rosenbloom;S A Jimenez

  • Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth

  • Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

    P. J. Clements;P. A. Lachenbruch;J. R. Seibold;B. Zee

  • Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study

    Fredrick M. Wigley;Robert A. Wise;James R. Seibold;Deborah A. McCloskey

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

    Philip J. Clements;Daniel E. Furst;Weng Kee Wong;Maureen Mayes

  • Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities

    Swati Bhattacharyya;Jun Wei;John Varga

  • Scleroderma: from cell and molecular mechanisms to disease models.

    David J. Abraham;John Varga

  • Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High‐dose versus low‐dose penicillamine trial

    Philip J. Clements;Eric L. Hurwitz;Weng Kee Wong;James R. Seibold

  • Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.

    Alain H. Rook;Bruce Freundlich;Brian V. Jegasothy;Maritza I. Perez

  • Transforming growth factor beta as a therapeutic target in systemic sclerosis.

    John Varga;Boris Pasche

  • Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators.

    Asish K. Ghosh;Weihua Yuan;Yasuji Mori;Shu Jen Chen

  • Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.

    Roberta Goncalves Marangoni;Benjamin D. Korman;Jun Wei;Tammara A. Wood

Frequent Co-Authors

Sergio A. Jimenez
Sergio A. Jimenez Thomas Jefferson University
Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Virginia D. Steen
Virginia D. Steen Georgetown University
Fredrick M. Wigley
Fredrick M. Wigley Johns Hopkins University
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Thomas A. Medsger
Thomas A. Medsger University of Pittsburgh
Richard M. Silver
Richard M. Silver Medical University of South Carolina
Philip J. Clements
Philip J. Clements University of California, Los Angeles
Christopher P. Denton
Christopher P. Denton University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative paths in the healthcare sector can offer flexibility and open new career opportunities beyond a traditional medical degree. Many students considering medicine may also be interested in graduate-level nursing, healthcare administration, or advanced nursing practice roles.

For those who wish to specialize in mental health, several institutions offer shortest post master's pmhnp online programs. These programs provide a streamlined route to becoming a Psychiatric Mental Health Nurse Practitioner.

If you are drawn to the business and management side of healthcare, pursuing a health care administration online degree could be an excellent choice. Such degrees focus on leadership, policy, and the operational aspects of healthcare organizations.

For those seeking advanced qualifications in administration, there are several cheapest mha online programs available. These affordable master’s degrees help you develop specialized management skills for healthcare settings.

Additionally, clinicians aiming for the highest practice roles can benefit from the cheapest dnp programs. A Doctor of Nursing Practice (DNP) enhances both clinical and leadership capabilities in advanced nursing.

Best Scientists Citing John Varga

Trending Scientists

Recently Published Articles